CD19 and type 2 diabetes mellitus: The present study was designed to evaluate the levels of total lymphocytes, B-lymphocytes (CD19+), T-lymphocytes (CD3+), NK cells, and monocyte subsets in patients with T2DM in Saudi Arabia and compare them to those found in healthy individuals.